about
90-kDa ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1.Calpain 3 is important for muscle regeneration: evidence from patients with limb girdle muscular dystrophies.Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy.Protein turnover and cellular stress in mildly and severely affected muscles from patients with limb girdle muscular dystrophy type 2I.Muscle atrophy reversed by growth factor activation of satellite cells in a mouse muscle atrophy model.Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity.Therapeutics for Duchenne muscular dystrophy: current approaches and future directions.Electroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle.Muscle involvement in limb-girdle muscular dystrophy with GMPPB deficiency (LGMD2T).A novel de novo mutation of the mitochondrial tRNAlys gene mt.8340G>a associated with pure myopathy.Functional improvement of dystrophic muscle by myostatin blockade.Resistance training in patients with limb-girdle and becker muscular dystrophies.Differential glucose metabolism in mice and humans affected by McArdle disease.Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.Phenotype and clinical course in a family with a new de novo Twinkle gene mutation.No muscle involvement in myoclonus-dystonia caused by epsilon-sarcoglycan gene mutations.Clinical heterogeneity and phenotype/genotype findings in 5 families with GYG1 deficiency.Limb girdle muscular dystrophy due to mutations in POMT2.Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.Collagen XII myopathy with rectus femoris atrophy and collagen XII retention in fibroblasts.Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy.Muscle regeneration in mitochondrial myopathies.A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the Common L276I Mutation Mimicking the Mild Phenotype in Humans.A pilot study of muscle plasma protein changes after exercise.Glycogen Synthesis in Glycogenin 1-Deficient Patients: A Role for Glycogenin 2 in Muscle.Sp1 and the ets-related transcription factor complex GABP alpha/beta functionally cooperate to activate the utrophin promoter.Identification of genes that are differentially expressed in extraocular and limb muscle.BAG3 myopathy is not always associated with cardiomyopathyProtein-carbohydrate supplements improve muscle protein balance in muscular dystrophy patients after endurance exercise: a placebo-controlled crossover studyEffect of sildenafil on skeletal and cardiac muscle in Becker muscular dystrophyMuscle regeneration and inflammation in patients with facioscapulohumeral muscular dystrophyLow survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse modelEndurance training: an effective and safe treatment for patients with LGMD2IDeletion of exon 16 of the dystrophin gene is not associated with diseaseMyostatin propeptide-mediated amelioration of dystrophic pathophysiologyShort- and long-term effects of endurance training in patients with mitochondrial myopathyMuscle biopsies off-set normal cellular signaling in surrounding musculatureAbsence of p.R50X Pygm read-through in McArdle disease cellular modelsExpanding the phenotype of filamin-C-related myofibrillar myopathy
P50
Q27863657-32044DE8-F1CC-4EB5-9BAD-FAB6573CF1A0Q34207404-AB94E914-1953-408E-8D0B-524817D6A680Q34285869-EE59221D-D4F0-41CA-9283-41ABF6242ACCQ34806120-513ACF64-C1C5-4870-8D62-C84A7701EDD3Q35194664-CD897FFE-2948-438C-AB8F-47417E47DE19Q35398252-8CD75816-0D6E-4992-AD28-FBBEA846BEE0Q35607136-75EAA403-D592-4E52-92B6-767A8E32EDF1Q37238941-1D125994-3193-48D2-BABE-7FC2A1BD7326Q37334305-8D8EED16-4670-4063-878B-4CC722F1C82DQ43869914-440F7572-D749-4E85-861B-824CF765F2CCQ44234792-B6E3598D-FBB8-4C03-A724-6079B681CC4FQ45974492-EC2AF268-649C-4B53-AABC-85B4B26F50E5Q46535269-96B507A8-3FE3-47BD-85FD-7AA52F7B8FBEQ46571361-DF46CEF8-D396-4315-BA4A-1EF2269386C7Q46658422-67C9F34E-DE0A-46EE-ACEB-ADD509D292D5Q46691080-763672E0-F6B7-4242-9840-486415A9BD57Q47152385-D6DEF654-D941-47A6-959E-4179B126C840Q47206584-D9624548-2B33-4812-84D0-4A09BF3CB278Q47366326-1B4C72EB-834B-40EA-91C5-B9E602631709Q48226149-32669363-BCC2-43CA-80A1-EC4C103763D6Q48481112-64568278-3307-4A3D-A43D-FC9439D3CD5DQ50495762-65FCD18B-BF51-4BEA-A7B7-88A15B5FFA3CQ50911860-082105CD-FB24-4DFE-9CDB-E24A7F636B07Q50953843-D308F87E-72EF-4826-8486-54DF7FE58F9BQ51029789-C4CF1DCF-0608-4CA3-8019-E608FFAC1314Q52596037-E3482AA3-9379-4A49-A815-08737D4FD4DCQ54032004-EE89024F-0CA3-412D-82ED-CF055C77F37BQ58455935-B13F0CFE-247E-4BA0-BE25-72943F86F456Q58818134-E9C26CA0-5B15-4E44-A64A-27BBD8D12CCCQ60772304-1CFAB668-A99F-434D-85DB-84A9B785D88BQ61805248-96782C56-9FA9-4169-8B58-04872CF3FC8DQ64121723-044D50B5-0A35-42E7-9615-D305479ACD4BQ79477415-2709B0FA-B785-4854-BA89-56A821AC9F78Q79568411-7D47AA26-1882-494D-A993-DC79F2EEB1B3Q81575700-81F92ACE-97EF-4E5D-AB8F-D84901B91F34Q83964665-BEB9467E-927A-4775-929F-8A405FFCA67BQ86570340-DB8AA3CD-635C-468A-B158-8A9A9724344FQ92057032-FB333721-7F42-4C41-9F79-9A32CE2E655AQ93369866-6935354B-4B0F-45C4-9727-78C7047F8F02
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Krag
@ast
Thomas Krag
@da
Thomas Krag
@de
Thomas Krag
@en
Thomas Krag
@es
Thomas Krag
@fo
Thomas Krag
@fr
Thomas Krag
@is
Thomas Krag
@kl
Thomas Krag
@nb
type
label
Thomas Krag
@ast
Thomas Krag
@da
Thomas Krag
@de
Thomas Krag
@en
Thomas Krag
@es
Thomas Krag
@fo
Thomas Krag
@fr
Thomas Krag
@is
Thomas Krag
@kl
Thomas Krag
@nb
altLabel
krag t
@en
krag to
@en
krag tob
@en
prefLabel
Thomas Krag
@ast
Thomas Krag
@da
Thomas Krag
@de
Thomas Krag
@en
Thomas Krag
@es
Thomas Krag
@fo
Thomas Krag
@fr
Thomas Krag
@is
Thomas Krag
@kl
Thomas Krag
@nb
P106
P108
P1416
P21
P31
P496
0000-0001-9330-668X